European Journal of Preventive Cardiology

Papers
(The H4-Index of European Journal of Preventive Cardiology is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Association of blood pressure classification using the 2017 ACC/AHA guidelines with the progression of coronary artery calcification347
Diastolic dysfunction of left ventricle as a consequence of lipotoxic myocardial damage in epicardial obesity283
Attainment of the 2019 ESC/EAS recommended LDL-C goal in Greek patients with established atherosclerotic cardiovascular disease142
Electrocardiogram characteristics of Black and Mixed-race young Brazilian football players: addressing the ‘African/Afro-Caribbean pattern’110
Secondary prevention after an acute cardiovascular event: far from targets and large room for improvement109
Refining prediction of stroke in sinus node dysfunction patients without atrial fibrillation using a P-combined score: a multi-centre study108
Homocysteine, a predictor of cardiovascular adverse events in coronary artery disease100
Cognitive impairment, health literacy, secondary prevention capacity and behaviours in acute coronary syndrome patients at early discharge: a prospective observational study97
Assessment of left ventricular myocardial deformation according to Speckle-tracking echocardiography in the long-term period in patients with takotsubo syndrome92
Stratifying the risk in chronic coronary syndromes: a ray of hope for ischaemia?82
Neuromuscular electrical stimulation in early rehabilitation of patients with postoperative complications after cardiovascular surgery81
Favourable lifestyle reduces cardiovascular disease risks in hypertensive patients72
Long-term physical activity time-in-target range in young adults with cardiovascular events in later life66
Artificial intelligence and anaerobic threshold: the winner is human physiology60
On the characterization of athlete’s heart using 3D echocardiography58
Effectiveness of a preoperative breathing exercises intervention on patients undergoing cardiac surgery: a systematic review55
Focus on cardiovascular risk factor control53
Gender Differences in Cardiovascular Events among Patients with Sleep Apnoea Syndrome: A Real-World Data Analysis of a Nationwide Epidemiological Dataset48
Autonomic cardiac control independently predicts incident hypertension and systolic blood pressure in a multi-ethnic population: The HELIUS study47
Association between alcohol consumption and peripheral artery disease: two de novo prospective cohorts and a systematic review with meta-analysis46
The mysterious lipoprotein(a): moving towards further understanding of its atherogenic role44
Does risk factor control beat familial predisposition for myocardial infarction?42
Day-to-day home blood pressure variability and risk of atrial fibrillation in a general Japanese population: the Hisayama Study41
Progrostic impact of a pre-existing heart failure with preserved ejection fraction in patients with acute pulmonary embolism or paroxysmal atrial fibrillation41
Clinical impact of transoesophageal echocardiography in acute brain ischaemia: who should we select?39
Exploring the physiological determinants of marathon performance38
Life"s simple 7 and the risk of stroke in Finnish men: a prospective cohort study38
Exercise-based cardiac rehabilitation: different angles to grasp its beauty37
Willingness of non-participants of conventional cardiac rehabilitation to participate in cardiac telerehabilitation: results of semi-structured interviews35
The role of histamine H2 receptor antagonist in heart failure: a potential game-changer?35
What people really know about hypertension and other cardiovascular disease risk factors. Recommendations vs reality34
Cardiac rehabilitation barriers in the Czech Republic: Determination of key barriers in East-Central Europe34
Telemedicine and health care pathway of atrial fibrillation patient34
An artificial intelligence model to predict 12-month mortality among patients with myocardial infarction33
Blood pressure target attainment according to the recent ESC cardiovascular prevention guidelines33
Bempedoic acid and PCSK9 inhibitor eligibility in a contemporary population with atherosclerotic cardiovascular disease33
Changes in antihypertensive treatment in surviving patients SARS-CoV-2 respiratory infection and its cardiovascular impact after one year of follow-up33
0.13253402709961